Current views on rejection pathology in liver transplantation
- 21 April 2010
- journal article
- review article
- Published by Frontiers Media SA in Transplant International
- Vol. 23 (10), 971-983
- https://doi.org/10.1111/j.1432-2277.2010.01143.x
Abstract
Histological assessments continue to play an important role in the diagnosis and management of liver allograft rejection. The changes occurring in acute and chronic rejection are well recognized and liver biopsy remains the 'gold standard' for diagnosing these two conditions. Recent interest has focused on the diagnosis of late cellular rejection, which may have different histological appearances to early acute rejection and instead has features that overlap with so-called 'de novo autoimmune hepatitis' and 'idiopathic post-transplant chronic hepatitis'. There is increasing evidence to suggest that 'central perivenulitis' may be an important manifestation of late rejection, although other causes of centrilobular necro-inflammation need to be considered in the differential diagnosis. There are also important areas of overlap between rejection and recurrent hepatitis C infection and the distinction between these two conditions continues to be a problem in the assessment of liver allograft biopsies. Studies using immunohistochemical staining for C4d as a marker for antibody-mediated damage have found evidence of C4d deposition in liver allograft rejection, but the functional significance of these observations is currently uncertain. This review will focus on these difficult and controversial areas in the pathology of rejection, documenting what is currently known and identifying areas where further clarification is required.Keywords
This publication has 94 references indexed in Scilit:
- Adult Living-Donor Liver Transplantation With ABO-Incompatible GraftsTransplantation, 2008
- Current status of liver transplantation across ABO blood-type barrierJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- C4d immunopositivity is uncommon in ABO‐compatible liver allografts, but correlates partially with lymphocytotoxic antibody statusHistopathology, 2007
- High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?Gut, 2007
- Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantationLiver Transplantation, 2006
- Antibodies against glutathione S-transferase T1 (GSTT1) in patients withde novoimmune hepatitis following liver transplantationClinical and Experimental Immunology, 2001
- Development of ductopaenic liver allograft rejection includes a “hepatitic” phase prior to duct lossJournal of Hepatology, 2000
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999
- Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease - possible association with a steroid-resistant transplant rejection episodeJournal of Hepatology, 1999
- STEROID WITHDRAWAL FROM LONG-TERM IMMUNOSUPPRESSION IN LIVER ALLOGRAFT RECIPIENTSTransplantation, 1993